Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeplat Energy Regulatory News (SEPL)

Share Price Information for Seplat Energy (SEPL)

Share Price is delayed by 15 minutes
Get Live Data
566.00    0.00 (0.00%)
Bid:
562.00
Ask:
566.00
Spread: 4.00 (0.712%)
Market Cap: £3.40b
SEPL Live PriceLast checked at - London Stock Exchange

Intraday Seplat Energy Share Chart

Stabilisation Notice

25 Mar 2021 09:38

RNS Number : 4892T
J.P. Morgan Securities PLC.
25 March 2021
 

25th March 21

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

Seplat Petroleum Development Company Plc

Pre-stabilisation Period Announcement

J.P. Morgan Securities plc, (contact: Emma Lovett 0207 134 2468) hereby gives notice, as Stabilisation Coordinator, that the Stabilising Manager(s) named below may stabilise the offer of the following securities in accordance with Commission Delegated Regulation EU/xxx/2016 under the Market Abuse Regulation (EU/596/2016).

The securities:

Issuer:

Seplat Petroleum Development Company Plc

Guarantor (if any):

N/A

Aggregate nominal amount:

USD bmk

Description:

USD 5-year-Non-Call-2-year Senior Unsecured Notes

Listing: London Stock Exchange

Offer price:

TBC

Other offer terms:

Denoms: USD 200,000 x USD 1,000

Stabilisation:

Stabilisation Manager(s):

J.P. Morgan Securities plc (Stabilisation coordinator)

Citi (Stabilisation Manager(s))

Standard Bank (Stabilisation Manager(s))

Standard Chartered Bank (Stabilisation Manager(s))

Natixis (Stabilisation Manager(s))

Rand Merchant Bank (Stabilisation Manager(s))

Societe Generale (Stabilisation Manager(s))

FCMB Capital Markets (Stabilisation Manager(s))

Nedbank (Stabilisation Manager(s))

United Bank for Africa (Stabilisation Manager(s))

Zenith Bank Plc (Stabilisation Manager(s))

Stabilisation period expected to start on:

25th March 21

Stabilisation period expected to end no later than:

25th March 2021

Existence, maximum size and conditions of use of overallotment facility:

The Stabilisation Manager(s) may over-allot the securities in an amount not exceeding 5% of the aggregate nominal amount stated above.

Stabilisation trading venue:

Over the counter, TBC

 

In connection with the offer of the above securities, the Stabilising Manager(s), or persons acting on behalf of the Stabilising Manager(s) may over-allot the securities, provided that the aggregate principal amount of the securities allotted does not exceed 105 percent of the aggregate principal amount of the securities, or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, stabilisation may not necessarily occur and any stabilisation action, if begun, may cease at any time, but it must end no later than the earlier of 30 days after the issue date of the securities and 60 days after the date of allotment of the securities.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within Article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that in that Member State

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STAEANDSADXFEEA
Date   Source Headline
26th Feb 20197:00 amRNSNotice of Results
27th Nov 20183:30 pmRNSDirector/PDMR Shareholding
15th Nov 201811:00 amRNSNotification on License Renewal
14th Nov 201811:56 amRNSQ3 2018 Interim Dividend Currency Exchange Rates
30th Oct 201811:58 amRNSCorporate Actions Announcement
30th Oct 20187:00 amRNSInterim Management Statement & Q3 2018 Results
17th Oct 20185:00 pmRNSNewspaper Publications
31st Aug 20182:01 pmRNSDirector/PDMR Shareholding
29th Aug 20188:00 amRNSListing of Bond on London Stock Exchange
13th Aug 20184:00 pmRNSCorporate Update
8th Aug 20182:00 pmRNSDirector/PDMR Shareholding
30th Jul 20187:00 amRNSConsolidated Half-Yearly Financial Results
25th Jul 20183:36 pmRNSNotice of Half Yearly Results
26th Jun 20183:50 pmRNSDirector/PDMR Shareholding
14th Jun 20184:56 pmRNSDirector/PDMR Shareholding
8th Jun 201810:26 amRNSResponse to Press Speculation
7th Jun 20183:07 pmRNSResult of AGM
17th May 20182:22 pmRNS2018 Interim Dividend Currency Exchange Rates
8th May 20184:52 pmRNSDirector/PDMR Shareholding
2nd May 201812:01 pmRNSRevised Corporate Actions Announcement
30th Apr 20187:00 amRNSCorporate Actions Announcement
30th Apr 20187:00 amRNSInterim Management Statement & Q1 2018 Results
30th Apr 20187:00 amRNS2017 Annual Report and Notice of AGM
29th Mar 20186:03 pmRNSSettlement of High Court Proceedings
21st Mar 20186:29 pmRNSAnnouncement of completion of bond offering
13th Mar 20187:00 amRNSSuccessful $300 million RCF refinancing
13th Mar 20187:00 amRNSAnnouncement of $350 million Bond Pricing
9th Mar 20185:00 pmRNSNotification of Share Dealings by PDMRs
28th Feb 201811:34 amRNSLaunch of U.S. Dollar denominated bond offering
28th Feb 20187:00 amRNSFull Year 2017 Financial Results
26th Feb 201810:19 amRNSAppointment of Executive Operations Director
26th Feb 20188:49 amRNSNotice of Results
2nd Feb 20187:00 amRNSVoting Rights and Issued Share Capital
23rd Oct 20177:00 amRNSInterim Management Statement & Q3 2017 Results
27th Jul 20177:00 amRNSConsolidated Half-Yearly Financial Results
24th Jul 20177:00 amRNSNotice of Half Yearly Results
3rd Jul 20177:00 amRNSOne year extension of revolving credit facility
19th Jun 20178:20 amRNSHolding(s) in Company
7th Jun 201712:10 pmRNSOperations update
2nd Jun 201710:04 amRNSResult of AGM
30th May 20177:00 amRNSHolding(s) in Company
28th Apr 20177:00 amRNSInterim Management Statement & Q1 2017 Results
26th Apr 20177:00 amRNS2016 Annual Report and Notice of AGM
24th Apr 201712:56 pmRNSDirector/PDMR Shareholding
4th Apr 20175:26 pmRNSDirector/PDMR Shareholding
3rd Apr 20177:00 amRNSDirector/PDMR Shareholding
31st Mar 20173:03 pmRNSRetirement of Mr. Stuart Connal
30th Mar 20177:00 amRNSFull Year 2016 financial results
23rd Mar 20177:00 amRNSNotice of Full Year 2016 Financial Results
3rd Feb 20172:24 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.